Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy
Status:
Terminated
Trial end date:
2014-04-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate SSP-004184AQ in patients with transfusional iron
overload whose primary diagnosis is hereditary or congenital anemia.
SSP-004184AQ is an iron chelator under development for chronic daily oral administration to
patients with transfusional iron overload.